High platelet count predicts poor prognosis in HCC patients undergoing TACE: a propensity score-matched analysis

References

• Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015 Mar;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Simonetti RG, Camma C, Fiorello F, et al. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci. 1991 Jul;36(7):962–972.
   PubMed Web of Science ®Google Scholar
• Fattovich G, Stroffolini T, Zagni I, et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004 Nov;127(5 Suppl 1):S35–50.
   PubMed Web of Science ®Google Scholar
• Kew MC. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol. 2010 Aug;58(4):273–277.
   PubMedGoogle Scholar
• Abdollahi M, Pouri A, Ghojazadeh M, et al. Non-invasive serum fibrosis markers: a study in chronic hepatitis. Bioimpacts. 2015;5(1):17–23.
   PubMedGoogle Scholar
• European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL Clinical Practice Guidelines: management of hepatocellular carcinoma. J Hepatol. 2018 Jul;69(1):182–236.
   PubMed Web of Science ®Google Scholar
• Llovet JM. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology. 2003 Feb; 37(2):429–442.
   PubMed Web of Science ®Google Scholar
• de Gaetano G. Historical overview of the role of platelets in hemostasis and thrombosis. Haematologica. 2001 Apr;86(4):349–356.
   PubMed Web of Science ®Google Scholar
• Franco AT, Corken A, Ware J. Platelets at the interface of thrombosis, inflammation, and cancer. Blood. 2015 Jul 30;126(5):582–588.
   PubMed Web of Science ®Google Scholar
• Gay LJ, Felding-Habermann B. Contribution of platelets to tumour metastasis. Nat Rev Cancer. 2011 Feb;11(2):123–134.
   PubMed Web of Science ®Google Scholar
• Yalmaz Y, Erdal E. Platelets, Microenvironment and Hepatocellular Carcinoma. Biochem Anal Biochem. 2016;5(2). https://doi.org/10.4172/2161-1009.1000281
   Google Scholar
• Buergy D, Wenz F, Groden C, et al. Tumor-platelet interaction in solid tumors. Int J Cancer. 2012 Jun 15;130(12):2747–2760.
   PubMed Web of Science ®Google Scholar
• Schwarz RE. Platelet counts and prognosis of pancreatic cancer. Lancet. 1999 Jun 19;353(9170):2158–2159.
   PubMed Web of Science ®Google Scholar
• Lee CH, Lin YJ, Lin CC, et al. Pretreatment platelet count early predicts extrahepatic metastasis of human hepatoma. Liver Int. 2015 Oct;35(10):2327–2336.
   PubMed Web of Science ®Google Scholar
• Scheiner B, Kirstein M, Popp S, et al. Association of Platelet Count and Mean Platelet Volume with Overall Survival in Patients with Cirrhosis and Unresectable Hepatocellular Carcinoma. Liver Cancer. 2019 May;8(3):203–217.
   PubMed Web of Science ®Google Scholar
• Roayaie S, Obeidat K, Sposito C, et al. Resection of hepatocellular cancer </=2 cm: results from two Western centers. Hepatology. 2013 Apr;57(4):1426–1435.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. American Association for the Study of Liver D. Management of hepatocellular carcinoma: an update. Hepatology. 2011 Mar;53(3):1020–1022.
   PubMed Web of Science ®Google Scholar
• Tang A, Cruite I, Sirlin CB. Toward a standardized system for hepatocellular carcinoma diagnosis using computed tomography and MRI. Expert Rev Gastroenterol Hepatol. 2013 Mar;7(3):269–279. eng.
   PubMed Web of Science ®Google Scholar
• Kee KM, Lu SN. Diagnostic efficacy of ultrasound in hepatocellular carcinoma diagnosis. Expert Rev Gastroenterol Hepatol. 2017 Apr;11(4):277–279.
   PubMed Web of Science ®Google Scholar
• Yoshiji H, Nagoshi S, Akahane T, et al. Evidence-based clinical practice guidelines for Liver Cirrhosis 2020. J Gastroenterol. 2021 Jul;56(7):593–619.
   PubMed Web of Science ®Google Scholar
• Lencioni R, de Baere T, Soulen MC, et al. Lipiodol transarterial chemoembolization for hepatocellular carcinoma: a systematic review of efficacy and safety data. Hepatology. 2016 Jul;64(1):106–116.
   PubMed Web of Science ®Google Scholar
• Lu J, Zhao M, Arai Y, et al. Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology (ISMIO). Hepatobiliary Surg Nutr. 2021;10(5):661–671.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010 Feb;30(1):52–60.
   PubMed Web of Science ®Google Scholar
• Tovoli F, Renzulli M, Negrini G, et al. Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib. Eur Radiol. 2018 Sep;28(9):3611–3620.
   PubMed Web of Science ®Google Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004 Nov 1;10(21):7252–7259.
   PubMed Web of Science ®Google Scholar
• Benedetto U, Head SJ, Angelini GD, et al. Statistical primer: propensity score matching and its alternatives. Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1112–1117.
   PubMed Web of Science ®Google Scholar
• Gasic GJ, Gasic TB, Stewart CC. Antimetastatic effects associated with platelet reduction. Proc Natl Acad Sci U S A. 1968 Sep;61(1):46–52.
   PubMed Web of Science ®Google Scholar
• Pavlovic N, Rani B, Gerwins P, et al. Platelets as Key Factors in Hepatocellular Carcinoma. Cancers (Basel). 2019 Jul 20;11(7):1022.
   Web of Science ®Google Scholar
• Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011 Nov 15;20(5):576–590.
   PubMed Web of Science ®Google Scholar
• Pipili-Synetos E, Papadimitriou E, Maragoudakis ME. Evidence that platelets promote tube formation by endothelial cells on matrigel. Br J Pharmacol. 1998 Nov;125(6):1252–1257.
   PubMed Web of Science ®Google Scholar
• Verheul HMW, Jorna AS, Hoekman K, et al. Vascular endothelial growth factor–stimulated endothelial cells promote adhesion and activation of platelets. Blood. 2000;96(13):4216–4221.
   PubMed Web of Science ®Google Scholar
• Wojtukiewicz MZ, Sierko E, Hempel D, et al. Platelets and cancer angiogenesis nexus. Cancer Metastasis Rev. 2017 Jun;36(2):249–262.
   PubMed Web of Science ®Google Scholar
• Semple JW, Italiano JE Jr., Freedman J. Platelets and the immune continuum. Nat Rev Immunol. 2011 Apr;11(4):264–274.
   PubMed Web of Science ®Google Scholar
• Compagnone G, Giampalma E, Domenichelli S, et al. Calculation of conversion factors for effective dose for various interventional radiology procedures. Med Phys. 2012 May;39(5):2491–2498.
   PubMed Web of Science ®Google Scholar
• Udell JA, Wang CS, Tinmouth J, et al. Does this patient with liver disease have cirrhosis? Jama. 2012;307(8):832–842.
   PubMed Web of Science ®Google Scholar
• Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int. 2017 Jun;37(6):778–793.
   PubMed Web of Science ®Google Scholar
• Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383(9930):1749–1761.
   PubMed Web of Science ®Google Scholar
• Sitia G, Iannacone M, Guidotti LG. Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma. J Hepatol. 2013 Nov;59(5):1135–1138. *Demonstrates the great potential of antiplatelet therapy in improving the prognosis of HCC patients.
   PubMed Web of Science ®Google Scholar